RISS 학술연구정보서비스

검색
다국어 입력

http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.

변환된 중국어를 복사하여 사용하시면 됩니다.

예시)
  • 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
  • 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
닫기
    인기검색어 순위 펼치기

    RISS 인기검색어

      KCI등재

      소아 천식의 표현형과 내재형 = REVIEW : Phenotype and endotype in pediatric asthma

      한글로보기
      • 내보내기
      • 내책장담기
      • 공유하기
      • 오류접수

      부가정보

      다국어 초록 (Multilingual Abstract)

      Asthma is not a homogeneous disease presenting variable clinical features, but a complex disorder consisting of many different disease entities characterized by variable air-flow limitation. To date, there are little effective preventive-strategies for the development of asthma, and it has been emphasized that early identification and intervention are the best ways to reduce the associated morbidities, quality of life, and socioeconomic burden. Predicting the natural course of asthma is still difficult, although various phenotypic approaches and predictive scores are developed and widely used. The present phenotypes and predictive scores may be reliable in the population, but those appear to be unreliable in each individual in real practice. Either undertreatment or overtreatment in childhood asthma is an important issue, because they are associated with poor compliance, increments of socioeconomic burdens, and poor quality of life. There is no doubt about the clinical efficacy of inhaled corticosteroid (ICS) in childhood asthma, but the negative effect of long-term use of ICS on the height is emerging. Therefore general physicians shouldconsider an individualized management using specific phenotypes and endotypes, and regularly re-evaluate the drug-response, level of control, and adherence/ compliance to avoid inadequate treatment. (Allergy Asthma Respir Dis 2 0 1 4;2:85-90)
      번역하기

      Asthma is not a homogeneous disease presenting variable clinical features, but a complex disorder consisting of many different disease entities characterized by variable air-flow limitation. To date, there are little effective preventive-strategies fo...

      Asthma is not a homogeneous disease presenting variable clinical features, but a complex disorder consisting of many different disease entities characterized by variable air-flow limitation. To date, there are little effective preventive-strategies for the development of asthma, and it has been emphasized that early identification and intervention are the best ways to reduce the associated morbidities, quality of life, and socioeconomic burden. Predicting the natural course of asthma is still difficult, although various phenotypic approaches and predictive scores are developed and widely used. The present phenotypes and predictive scores may be reliable in the population, but those appear to be unreliable in each individual in real practice. Either undertreatment or overtreatment in childhood asthma is an important issue, because they are associated with poor compliance, increments of socioeconomic burdens, and poor quality of life. There is no doubt about the clinical efficacy of inhaled corticosteroid (ICS) in childhood asthma, but the negative effect of long-term use of ICS on the height is emerging. Therefore general physicians shouldconsider an individualized management using specific phenotypes and endotypes, and regularly re-evaluate the drug-response, level of control, and adherence/ compliance to avoid inadequate treatment. (Allergy Asthma Respir Dis 2 0 1 4;2:85-90)

      더보기

      참고문헌 (Reference)

      1 Agache I, "Untangling asthma phenotypes and endotypes" 67 : 835-846, 2012

      2 Taussig LM, "Tucson Children's Respiratory Study: 1980 to present" 111 : 661-675, 2003

      3 Zhang G, "The era of genome-wide association studies: opportunities and challenges for asthma genetics" 54 : 624-628, 2009

      4 Castro-Rodriguez JA, "The Asthma Predictive Index: a very useful tool for predicting asthma in young children" 126 : 212-216, 2010

      5 Wenzel S, "Severe asthma: from characteristics to phenotypes to endotypes" 42 : 650-658, 2012

      6 Fitzpatrick AM, "Severe asthma in children: insights from the national heart, lung, and blood institute's severe asthma research program" 23 : 131-138, 2010

      7 Herr M, "Risk factors and characteristics of respiratory and allergic phenotypes in early childhood" 130 : 389-96.e4-, 2012

      8 Holt PG, "Prevention of allergic respiratory disease in infants: current aspects and future perspectives" 7 : 547-555, 2007

      9 Caudri D, "Predicting the long-term prognosis of children with symptoms suggestive of asthma at preschool age" 124 : 903-10.e1-903-10.e7, 2009

      10 Kurukulaaratchy RJ, "Predicting persistent disease among children who wheeze during early life" 22 : 767-771, 2003

      1 Agache I, "Untangling asthma phenotypes and endotypes" 67 : 835-846, 2012

      2 Taussig LM, "Tucson Children's Respiratory Study: 1980 to present" 111 : 661-675, 2003

      3 Zhang G, "The era of genome-wide association studies: opportunities and challenges for asthma genetics" 54 : 624-628, 2009

      4 Castro-Rodriguez JA, "The Asthma Predictive Index: a very useful tool for predicting asthma in young children" 126 : 212-216, 2010

      5 Wenzel S, "Severe asthma: from characteristics to phenotypes to endotypes" 42 : 650-658, 2012

      6 Fitzpatrick AM, "Severe asthma in children: insights from the national heart, lung, and blood institute's severe asthma research program" 23 : 131-138, 2010

      7 Herr M, "Risk factors and characteristics of respiratory and allergic phenotypes in early childhood" 130 : 389-96.e4-, 2012

      8 Holt PG, "Prevention of allergic respiratory disease in infants: current aspects and future perspectives" 7 : 547-555, 2007

      9 Caudri D, "Predicting the long-term prognosis of children with symptoms suggestive of asthma at preschool age" 124 : 903-10.e1-903-10.e7, 2009

      10 Kurukulaaratchy RJ, "Predicting persistent disease among children who wheeze during early life" 22 : 767-771, 2003

      11 Spycher BD, "Phenotypes of childhood asthma: are they real?" 40 : 1130-1141, 2010

      12 Campo P, "Phenotypes and endotypes of uncontrolled severe asthma: new treatments" 23 : 76-88, 2013

      13 Rehan VK, "Perinatal nicotine exposure induces asthma in second generation offspring" 10 : 129-, 2012

      14 Berry M, "Pathological features and inhaled corticosteroid response of eosinophilic and non-eosinophilic asthma" 62 : 1043-1049, 2007

      15 Just J, "Novel severe wheezy young children phenotypes: boys atopic multiple-trigger and girls nonatopic uncontrolled wheeze" 130 : 103-10.e8-, 2012

      16 Weidinger S, "Loss-of-function variations within the filaggrin gene predispose for atopic dermatitis with allergic sensitizations" 118 : 214-219, 2006

      17 Bisgaard H, "Long-term studies of the natural history of asthma in childhood" 126 : 187-197, 2010

      18 Grad R, "Long-term outcomes of early-onset wheeze and asthma" 130 : 299-307, 2012

      19 Anandan C, "Is the prevalence of asthma declining? Systematic review of epidemiological studies" 65 : 152-167, 2010

      20 Li LB, "Inhibition of histone deacetylase 2 expression by elevated glucocorticoid receptor beta in steroid-resistant asthma" 182 : 877-883, 2010

      21 Giubergia V, "Influence of β(2)-adrenergic receptor polymorphisms on asthma exacerbation in children with severe asthma regularly receiving salmeterol" 110 : 156-160, 2013

      22 Simpson JL, "Inflammatory subtypes in asthma: assessment and identification using induced sputum" 11 : 54-61, 2006

      23 Goleva E, "Increased glucocorticoid receptor beta alters steroid response in glucocorticoid-insensitive asthma" 173 : 607-616, 2006

      24 Holloway JW, "Genetics of allergic disease" 125 (125): S81-S94, 2010

      25 Moffatt MF, "Genetic variants regulating ORMDL3 expression contribute to the risk of childhood asthma" 448 : 470-473, 2007

      26 The Global Initiative for Asthma, "GINA Report, Global strategy for asthma management and prevention" The Global Initiative for Asthma

      27 Agache IO, "From phenotypes to endotypes to asthma treatment" 13 : 249-256, 2013

      28 Palmer CN, "Filaggrin null mutations are associated with increased asthma severity in children and young adults" 120 : 64-68, 2007

      29 Chen LC, "Evaluation of a common variant of the gene encoding clara cell 10 kd protein (CC10) as a candidate determinant for asthma severity and steroid responsiveness among Chinese children" 49 : 665-672, 2012

      30 Tezza G, "Epigenetics of allergy" 89 (89): S20-S21, 2013

      31 Kabesch M, "Epigenetic mechanisms and the relationship to childhood asthma" 36 : 950-961, 2010

      32 Cortessis VK, "Environmental epigenetics: prospects for studying epigenetic mediation of exposure-response relationships" 131 : 1565-1589, 2012

      33 Ho SM, "Environmental epigenetics of asthma: an update" 126 : 453-465, 2010

      34 Anderson GP, "Endotyping asthma: new insights into key pathogenic mechanisms in a complex, heterogeneous disease" 372 : 1107-1119, 2008

      35 Szefler SJ, "Early asthma: stepping closer to primary prevention" 130 : 308-310, 2012

      36 Spycher BD, "Distinguishing phenotypes of childhood wheeze and cough using latent class analysis" 31 : 974-981, 2008

      37 Bacharier LB, "Diagnosis and management of early asthma in preschool-aged children" 130 : 287-296, 2012

      38 Brand PL, "Definition, assessment and treatment of wheezing disorders in preschool children: an evidence-based approach" 32 : 1096-1110, 2008

      39 Palmer CN, "Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis" 38 : 441-446, 2006

      40 Lee YJ, "Clinical characteristics of eosinophilic and noneosinophilic asthma in children" 102 : 53-57, 2013

      41 Bisgaard H, "Chromosome 17q21 gene variants are associated with asthma and exacerbations but not atopy in early childhood" 179 : 179-185, 2009

      42 Rao CK, "Characteristics of perimenstrual asthma and its relation to asthma severity and control: data from the Severe Asthma Research Program" 143 : 984-992, 2013

      43 Guilbert TW, "Atopic characteristics of children with recurrent wheezing at high risk for the development of childhood asthma" 114 : 1282-1287, 2004

      44 Caudri D, "Asthma symptoms and medication in the PIAMA birth cohort: evidence for under and overtreatment" 22 : 652-659, 2011

      45 Weinmayr G, "Asthma phenotypes identified by latent class analysis in the ISAAC phase II Spain study" 43 : 223-232, 2013

      46 Lotvall J, "Asthma endotypes: a new approach to classification of disease entities within the asthma syndrome" 127 : 355-360, 2011

      47 Runyon RS, "Asthma discordance in twins is linked to epigenetic modifications of T cells" 7 : e48796-, 2012

      48 Martinez FD, "Asthma and wheezing in the first six years of life. The Group Health Medical Associates" 332 : 133-138, 1995

      49 Henderson J, "Associations of wheezing phenotypes in the first 6 years of life with atopy, lung function and airway responsiveness in mid-childhood" 63 : 974-980, 2008

      50 Van Eerdewegh P, "Association of the ADAM33 gene with asthma and bronchial hyperresponsiveness" 418 : 426-430, 2002

      51 Song GG, "Association between ADAM33 S2 and ST+4 polymorphisms and susceptibility to asthma: a meta-analysis" 524 : 72-78, 2013

      52 Fu A, "An environmental epigenetic study of ADRB2 5'-UTR methylation and childhood asthma severity" 42 : 1575-1581, 2012

      53 Lopuhaa CE, "Allergen-induced bronchial inflammation in house dust mite-allergic patients with or without asthma" 32 : 1720-1727, 2002

      54 Szefler SJ, "Advances in pediatric asthma in 2011: moving forward" 129 : 60-68, 2012

      55 Basu K, "Adrenergic beta(2)-receptor genotype predisposes to exacerbations in steroid-treated asthmatic patients taking frequent albuterol or salmeterol" 124 : 1188-94.e3-, 2009

      56 Moffatt MF, "A large-scale, consortium-based genomewide association study of asthma" 363 : 1211-1221, 2010

      57 Yunginger JW, "A community-based study of the epidemiology of asthma. Incidence rates, 1964-1983" 146 : 888-894, 1992

      58 Castro-Rodriguez JA, "A clinical index to define risk of asthma in young children with recurrent wheezing" 162 (162): 1403-1406, 2000

      59 Blekic M, "17q12-21 and asthma: interactions with early-life environmental exposures" 110 : 347-53.e2-, 2013

      더보기

      동일학술지(권/호) 다른 논문

      동일학술지 더보기

      더보기

      분석정보

      View

      상세정보조회

      0

      Usage

      원문다운로드

      0

      대출신청

      0

      복사신청

      0

      EDDS신청

      0

      동일 주제 내 활용도 TOP

      더보기

      주제

      연도별 연구동향

      연도별 활용동향

      연관논문

      연구자 네트워크맵

      공동연구자 (7)

      유사연구자 (20) 활용도상위20명

      인용정보 인용지수 설명보기

      학술지 이력

      학술지 이력
      연월일 이력구분 이력상세 등재구분
      2026 평가예정 재인증평가 신청대상 (재인증)
      2020-01-01 평가 등재학술지 유지 (재인증) KCI등재
      2017-01-01 평가 등재학술지 선정 (계속평가) KCI등재
      2016-12-01 평가 등재후보로 하락 (계속평가) KCI등재후보
      2013-04-05 학술지명변경 한글명 : 대한소아알레르기및호흡기학회지 -> Allergy Asthma & Respiratory Diseases
      외국어명 : THE Korean Academy of Pediatric Allergy and Respiratory Disease -> 알레르기 천식 호흡기질환
      KCI등재
      2010-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2009-01-01 평가 등재 1차 FAIL (등재유지) KCI등재
      2007-05-30 학회명변경 한글명 : 대한소아알레르기 및 호흡기학회 -> 대한 소아알레르기 호흡기학회 KCI등재
      2006-01-01 평가 등재학술지 선정 (등재후보2차) KCI등재
      2005-01-01 평가 등재후보 1차 PASS (등재후보1차) KCI등재후보
      2004-01-01 평가 등재후보학술지 유지 (등재후보1차) KCI등재후보
      2003-01-01 평가 등재후보 1차 FAIL (등재후보1차) KCI등재후보
      2001-07-01 평가 등재후보학술지 선정 (신규평가) KCI등재후보
      더보기

      학술지 인용정보

      학술지 인용정보
      기준연도 WOS-KCI 통합IF(2년) KCIF(2년) KCIF(3년)
      2016 0.34 0.34 0.49
      KCIF(4년) KCIF(5년) 중심성지수(3년) 즉시성지수
      0.41 0.41 0.971 0.19
      더보기

      이 자료와 함께 이용한 RISS 자료

      나만을 위한 추천자료

      해외이동버튼